The largest database of trusted experimental protocols

Hr scanner

Manufactured by Siemens

The HR+ scanner is a high-resolution imaging device designed for laboratory applications. Its core function is to capture detailed images and data for analytical and research purposes. The HR+ scanner utilizes advanced imaging technology to provide users with precise and accurate measurements and visualizations of samples or specimens.

Automatically generated - may contain errors

Lab products found in correlation

15 protocols using hr scanner

1

Quantifying Opioid Receptor Availability with [C-11]Carfentanil PET

Check if the same lab product or an alternative is used in the 5 most similar protocols
Scans were acquired with a Siemens (Knoxville, TN) HR+ scanner in three-dimensional mode [reconstructed full width at half-maximum (FWHM) resolution, ~5.5 mm in-plane and 5.0 mm axially], with septa retracted and scatter correction. Participants were positioned in the PET scanner gantry, and an intravenous (antecubital) line was placed in the right arm. A light forehead restraint was used to eliminate intra-scan head movement. [11C]-carfentanil was synthesized at high specific activity by the reaction of [11C]-methyliodide and a nonmethyl precursor as described previously.37 (link) 15 +/− 1 mCi (555 +/− 55 MBq) were administered during the scan. Receptor occupancy by carfentanil was calculated to be between 0.2 and 0.6% for brain regions with low, intermediate, and high MOR concentrations, based on the mass of carfentanil administered and the known concentration of opioid receptors in the postmortem human brain.20 (link); 27 (link) Fifty percent of the [11C]-carfentanil dose was administered as a bolus, and the remaining 50% was administered by continuous infusion for the remainder of the study. Twenty-eight frames of images were acquired over 90 min with an increasing duration (30 seconds up to 10 minutes).
+ Open protocol
+ Expand
2

PET Imaging of μ-Opioid Receptors

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used the selective μOR radioligand, [11C]carfentanil for the PET sessions.5 (link) Each session was 90 min, with 40 min of baseline acquisition, followed by 20 min of a STPT challenge (more information below). As described in our previous study,3 [11C]carfentanil was produced using a cycloton in the vicinity.6 (link) PET scans were acquired with a Siemens HR+ scanner in 3-D mode (reconstructed FWHM resolution 5.5 mm in-plane and 5.0 mm axially) with septa retracted and scatter correction. Subjects were positioned in the PET scanner gantry and two intravenous (antecubital) lines were placed. Each dose of [11C]carfentanil (15 ± 1 mCi, ≤0.03 μg/kg) was administered fifty percent as a bolus, and the remaining dose was continuously injected across the scan session to achieve steady-state tracer levels around 35 min after tracer administration.
+ Open protocol
+ Expand
3

PET Imaging Protocol for Raclopride

Check if the same lab product or an alternative is used in the 5 most similar protocols
PET scans were acquired with a Siemens (Knoxville, TN) HR+ scanner in 3-D mode (reconstructed full-width at half maximum resolution, ∼5.5 mm in-plane and 5.0 mm axially). Radiotracer synthesis and image acquisition, coregistration and reconstruction protocols were identical to those used previously (Weiland et al., 2014 (link)). Briefly, images were reconstructed, attenuation and motion corrected, and co-registered to each other (Minoshima et al., 1993 (link)). Time points were then decay-corrected during data reconstruction. Approximately 15 millicuries (mCi) was administered for each scan (<40 μg total cold mass for raclopride). Fifty percent of the radiotracer dose was administered as a bolus with the remainder delivered as a continuous infusion which allows for more rapid equilibration across compartments and is achieved within 5 min of radiotracer administration (Watabe et al., 2000). Twenty-eight image frames were acquired over 90 minutes with an increasing duration (30 seconds up to 10 minutes).
+ Open protocol
+ Expand
4

MR Quantification of Plaster Formulations

Check if the same lab product or an alternative is used in the 5 most similar protocols
Quantitative MR parameter mapping was performed on a 3T GE MR750 scanner (GE Healthcare, Waukesha, WI). All scans for MR quantification used a 3D gradient echo sequence with ultrashort echo times (UTE) and radial readouts in order to maximize signal from the plaster (Fig. 1). A single-channel quadrature head coil was used to provide more uniform B1 homogeneity. T1 quantification used a variable flip angle (VFA) approach15 (link),16 (link) with flip angles of 8 and 44 degrees; the TE for these scans was 24 microseconds, with a TR of 6.4 milliseconds. T2* quantification was performed using a multi-echo sequence with 32 echo times ranging from 24 microseconds to 5 milliseconds17 (link); these scans used an 8 degree flip angle and a TR of 9.276 milliseconds. The reconstructed images were 256×256 with 108 slices and 2mm isotropic voxels.
68Ge transmission scans were acquired on a Siemens HR+ scanner. This scanner is equipped with 3 rotating 68Ge lines source (approximately 70MBq each), and 45 minutes transmission scans were performed for each arrangement of 19 containers.. These data provided direct quantitative measurement of the 511 keV photon attenuation coefficients of the different plaster formulations.
+ Open protocol
+ Expand
5

Quantifying Dopamine D2/3 Receptor Availability

Check if the same lab product or an alternative is used in the 5 most similar protocols
[11C]raclopride scans were acquired on a Siemens HR+ scanner and some of the data was reported previously for different study purposes [24 (link)–26 ]. Scans were conducted on two separate days: once 2 min after 3 ml intravenous saline placebo (to assess baseline dopamine D2/3 receptor availability) and once 2 min after 0.5 mg/kg intravenous methylphenidate (single blind; counterbalanced session order). Details on this PET scanning protocol have been previously described [25 (link)]. In short, emission scans were started immediately after injection of 4–8 mCi (spe- cific activity 500–1500 mCi/μmol at end of bombardment). Twenty-one dynamic emission scans were obtained from time of injection for a total of 60 min and arterial sampling was used to quantify total carbon-11 and unchanged [11C]raclopride in plasma. Additionally, the dynamic emission scan images were evaluated before analyses to ensure that any motion artifacts or misplacements were not included.
+ Open protocol
+ Expand
6

Quantifying Dopamine Transporter Availability

Check if the same lab product or an alternative is used in the 5 most similar protocols
Measures of hDAT availability in the human brain had been collected using PET and [11C]cocaine, a radioligand to measure hDAT, and retrieved from the imaging dataset of the BNL Brain Imaging Center. All PET scans were performed on a Siemens, HR+ scanner in 3D mode via procedures as reported35 (link) along with the analytical approach to quantify the availability, which was estimated as Bmax/KD36 (link), 37 (link). For this study we only used data obtained in 62 healthy male controls (average age at 35.1 years with a standard deviation of 6.7; N=27 African Americans, 28 Caucasians, 3 Hispanics, and 4 multiracial).
+ Open protocol
+ Expand
7

PET Imaging of Mu-Opioid Receptor Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used the selective μ-opioid receptor radioligand, [11C]carfentanil for the PET sessions4 (link). Each session was 90 minutes, with 40 minutes of baseline acquisition, followed by 20 min of a STPT challenge (more information below). As described in our previous study (DaSilva AF et al. Association of μ-Opioid Activation in the PreFrontal Cortex with Spontaneous Migraine Attacks – Brief Report I. Submitted, 2013), [11C]carfentanil was produced using a cycloton in the vicinity5 (link). PET scans were acquired with a Siemens HR+ scanner in 3-D mode (reconstructed FWHM resolution 5.5 mm in-plane and 5.0 mm axially) with septa retracted and scatter correction. Subjects were positioned in the PET scanner gantry and two intravenous (antecubital) lines were placed. Each dose of [11C]carfentanil (15± 1 mCi, ≤ 0.03 μg/kg) was administered fifty percent as a bolus, and the remaining dose was continuously injected across the scan session to achieve steady-state tracer levels around 35 minutes after tracer administration.
+ Open protocol
+ Expand
8

Quantifying D2/D3 Receptor Availability

Check if the same lab product or an alternative is used in the 5 most similar protocols
All [11C]raclopride scans were performed on a Siemens, HR+ scanner (resolution 4.5 × 4.5 × 4.5 mm full width half-maximum, 63 slices) at the BNL PET Imaging Center. The procedures for subjects positioning and scanning protocols have been described previously [25 (link), 28 (link)]. In short, emission scans were started immediately after injection of 4–8 mCi (specific activity 0.5–1.5 Ci/µM at end of bombardment or EOB). Twenty dynamic emission scans were obtained from time of injection up to 60 min and arterial sampling was used to quantify total carbon-11 and unchanged [11C]raclopride in plasma.
We calculated regional Bmax/KD values for hand-drawn caudate, putamen and ventral striatum (VS) regions of interest (ROIs) using a procedure previously described [29 (link)]. ROIs had the same size and shape across subjects. The ratio of the distribution volume in striatal regions was computed to that in the cerebellum to obtain the non-displaceable binding potential (BPND), which was used as a quantification of D2/D3R availability and corresponds to Bmax/Kd – 1 [11 ].
+ Open protocol
+ Expand
9

PET Imaging of Amphetamine Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
Subjects underwent two PET scans on one day with [11C]FLB457 at the Yale University PET Center. A 90 min baseline scan was acquired, followed immediately by oral administration of amphetamine (0.5 mg/kg) and a second 90 min scan 3 hr after amphetamine administration. Arterial plasma data were collected to form metabolite-corrected input functions. Data were acquired on an HR+ scanner (Siemens, Knoxville TN) and reconstructed by filtered back projection with correction for attenuation, randoms and scatter. Data were binned into a sequence of frames of increasing duration.
+ Open protocol
+ Expand
10

PET Imaging of μOR Receptor Binding

Check if the same lab product or an alternative is used in the 5 most similar protocols
PET sessions with CFN, a selective and specific μOR radioligand7 (link) were performed for 90 min. PET scans were acquired with a Siemens HR+ scanner in 3D mode (reconstructed FWHM resolution 5.5 mm in-plane and 5.0 mm axially) with septa retracted and scatter correction. Subjects were positioned in the PET scanner gantry and two intravenous (antecubital) lines were placed. CFN was produced using a cycloton in the vicinity,8 (link) and each dose (15 ± 1 mCi, ≤0.03 μg/kg) was administered 50% as a bolus with the remainder continuously infused over the course of the scan to achieve steady-state tracer levels ∼35 min after tracer administration.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!